Insulin Resistance Peptide (MOTS-C)
Insulin Resistance Peptide (MOTS-C)
MOTS-C is a mitochondrial-derived peptide that plays a crucial role in metabolic regulation and insulin sensitivity.
What Does MOTS-C Therapy Include?
- Subcutaneous injections to enhance mitochondrial function
- Support for improved glucose metabolism and energy production
- Fat-burning and metabolic efficiency enhancement
- Regular monitoring to track insulin sensitivity improvements
- Personalized treatment plans for metabolic health
Benefits of MOTS-C Therapy
- Enhances insulin sensitivity and glucose utilization
- Promotes fat loss and metabolic health
- Supports energy production and endurance
- Improves resistance to metabolic stress
Freequently Asked Questions
It enhances mitochondrial function, improving the body’s ability to utilize glucose efficiently.
Individuals with metabolic disorders, insulin resistance, or weight management goals.
It is given as a subcutaneous injection.
MOTS-C is well-tolerated, with minimal reported side effects.
Improvements in energy and glucose metabolism can be seen within weeks.